Sign In
Buy DRIO
$7.50
-0.1000 (-1.32%)
At Close: Jun 05, 2026
Recap: DarioHealth Q1 Earnings
11:06am, Tuesday, 12'th May 2020
Shares of DarioHealth (NASDAQ:DRIO) remained unaffected at $7.95 after the company reported Q1 results.Quarterly Results Earnings per share fell 946.67% year over year to ($1.57), which missed the est
DarioHealth Reports First Quarter 2020 Results
11:00am, Tuesday, 12'th May 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the first quarter 2020 and provided a corporate and commercial update.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, lim
DarioHealth poaches former Catasys execs, launches behavioral health coaching
10:45pm, Tuesday, 05'th May 2020
DarioHealth, a digital health company focused on patients with diabetes and hypertension, rolled out behavioral health coaching for its users.
DarioHealth to Report Financial Results for the First Quarter 2020 Results on May 12
01:00pm, Tuesday, 05'th May 2020
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its first quarter ended March 31, 2020 financial resul
DarioHealth Expands Offering to Include Behavioral Health
12:30pm, Monday, 04'th May 2020
DarioHealth Corp. (Nasdaq: DRIO), a leading global digital therapeutics (DTx) innovator, announced today that it has expanded its offering on its chronic care platform application to include behaviora
DarioHealth Expands Remote Care Offering With Integration of Full-Service Telemedicine
12:30pm, Wednesday, 29'th Apr 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in global digital therapeutics (DTx), announced today a new partnership with value-based telemedicine provider MediOrbis to expand Dario's existing service
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.13%
12:00am, Tuesday, 28'th Apr 2020
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.13%
Can DarioHealth (NASDAQ:DRIO) Afford To Invest In Growth?
02:10pm, Saturday, 18'th Apr 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Edited Transcript of DRIO earnings conference call or presentation 17-Mar-20 12:30pm GMT
03:59pm, Monday, 06'th Apr 2020
Q4 2019 DarioHealth Corp Earnings Call
DarioHealth® Announces Key New Hires Expanding Its Management Depth in the Employer and Managed Care Markets
12:30pm, Thursday, 26'th Mar 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the appointment of Omar Manejwala, M.D to the newly created position of Chief Medical Officer, an
Reviewing DarioHealth (NASDAQ:DRIO) & Atrion (NASDAQ:ATRI)
06:28am, Thursday, 26'th Mar 2020
DarioHealth (NASDAQ:DRIO) and Atrion (NASDAQ:ATRI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, v
Dario Diabetes Management Is Recognized as a Leading Application for Children/Young People Self-managing Healthcare During COVID-19 Pandemic
12:30pm, Wednesday, 25'th Mar 2020
DarioHealth Corp. (NASDAQ: DRIO), a global digital therapeutics (DTx) innovator, announced today an endorsement from the U.K. based ORCHA, highlighting the Company's Diabetes Management Application as
